Effects of combined and low-dose gestagen oral contraceptives on plasma lipids; including individual phospholipids.
D000293:Adolescent; D000328:Adult; D002715:Chlormadinone Acetate / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004304:Dosage Forms; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008244:Lysophosphatidylcholines / Q000097:blood; D008656:Mestranol / Q000494:pharmacology*; D008875:Middle Aged; D009640:Norethindrone / Q000494:pharmacology*; D010713:Phosphatidylcholines / Q000097:blood; D010714:Phosphatidylethanolamines / Q000097:blood; D010743:Phospholipids / Q000097:blood; D013109:Sphingomyelins / Q000097:blood; D014280:Triglycerides / Q000097:blood
D003276:Contraceptives, Oral; D004304:Dosage Forms; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D008244:Lysophosphatidylcholines; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D013109:Sphingomyelins; D014280:Triglycerides; D002715:Chlormadinone Acetate; D002784:Cholesterol; D008656:Mestranol; D009640:Norethindrone